Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy

Toll-like receptor 3 (TLR3), as an important pattern recognition receptor (PRR), dominates the innate and adaptive immunity regulating many acute and chronic inflammatory diseases. Atherosclerosis is proved as an inflammatory disease, and inflammatory events involved in the entire process of initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cen, Xiaohong, Wang, Baoqu, Liang, Yuqing, Chen, Yanlin, Xiao, Yu, Du, Shaohua, Nandakumar, Kutty Selva, Yin, Hang, Liu, Shuwen, Cheng, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513496/
https://www.ncbi.nlm.nih.gov/pubmed/36176917
http://dx.doi.org/10.1016/j.apsb.2022.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513496/
https://www.ncbi.nlm.nih.gov/pubmed/36176917
http://dx.doi.org/10.1016/j.apsb.2022.06.001

Ejemplares similares